Search | IOVS | ARVO Journals

View

Showing 1 – 4 of 4

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract September 2016

Generation and characterization of CLG561: a fully-human, anti-properdin Fab for the treatment of age-related macular degeneration

Leslie Johnson; Igor Splawski; Lisa Baker; Ana Carrion; Anh Nguyen; Michael Twarog; Yiqin Wang; Ute Jager; Mark Keating; Thaddeus P Dryja; Michael Roguska

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1116. doi:

ARVO Annual Meeting Abstract April 2014

Generation and Characterization of LFG316, A Fully-Human Anti-C5 Antibody for the Treatment of Age-Related Macular Degeneration

Michael Roguska; Igor Splawski; Beate Diefenbach-Streiber; Elizabeth Dolan; Bijan Etemad-Gilbertson; Jean-Michel Rondeau; Mark Keating

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3433. doi:

ARVO Annual Meeting Abstract May 2008

Interphotoreceptor Retinoid-Binding Protein (IRBP) Binds Cone Outer Segments Differentially in Light and Dark Adapted Xenopus Retina

A. M. Keating; M. Garlipp; F. Gonzalez-Fernandez

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):3531. doi:

ARVO Annual Meeting Abstract May 2007

Suppression of Retinal Inflammation in Endotoxin-Induced Uveitis by the Kinase Inhibitor, PKC412

S.-M. Liao; O. Deldago; D. Yoo; M. Keating; B. Jaffee

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):2637. doi:

Advertisement